Home › Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.
 

Keywords :   


Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.

2014-12-28 20:11:35| Biotech - Topix.net

Pharmaceutical companies have had some of the best-performing stocks over the last couple of years thanks to an innovation boom that has produced a host of new game-changing drugs, from Gilead Sciences ' revolutionary new cancer treatment Keytruda. Pharma stocks have crushed the broader market in recent years, as shown by the incredible performance of the iShares Nasdaq Biotech Index to favor its newly approved hepatitis C therapy Viekira Pak for genotype 1 patients, over Gilead's competing drugs, appears to mark a sea change in the pharma landscape that could trigger a major reversal in these stocks.

Tags: why deep trouble stocks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Who is Paula Vennells? Ex-Post Office boss in Horizon IT inquiry
16.05EU sees significant increase in African swine fever outbreaks in 2023
16.05BASF Expands Biomass Balance Portfolio for Selected Chemical Intermediates
16.05INDA Releases 11th Annual North America Supply Report
16.05Dow and SCGC Partner to Change 200KTA of Plastic Waste Into Circular Products
16.05Leanpath Uses Generative AI to Drive Action on Food Waste Data
16.05AkzoNobels Como Site Achieves Highest Automotive Industry Quality Certification
16.05ECONWARDs Counterplan for Landfill-Bound Organics
More »